The national radiology practice Optimal Radiology has brought industry veteran Joseph “Joe” McDonough, formerly of Soteria Imaging Services, on board as the firm’s new chief executive officer

More conservative diagnostic thresholds, published Oct. 10 in the New England Journal of Medicine (NEJM), will help reduce the risk that a possibly normal first trimester pregnancy is misdiagnosed as nonviable, say experts from radiology, obstetrics-gynecology and emergency medicine

A study published online on October 7 by the Journal of the American Medical Association (JAMA) finds that postoperative venous thromboembolism (VTE) rates are likely not a good measure of hospital quality because hospitals that routinely order more imaging studies find more VTE events

President Obama has signed H.R. 527, the "Helium Stewardship Act of 2013," into law, authorizing the Secretary of the Interior to continue to sell crude helium from the Federal Helium Reserve until September 30, 2014, and avoiding disruption to the helium supply that could hurt MR manufacturers, MR users and all other industries that depend on a stable helium supply

Health care lobbyists tell Washington, D.C., news source The Hill that they are close to winning a repeal of the 2.3% medical device excise tax included in the Affordable Care Act (ACA), and the mounting pressure on both parties to compromise on a government funding and debt ceiling deal may be working in their favor

In order to improve Lexmark’s Perceptive healthcare content management and workflow solutions and vendor neutral archive (VNA), Lexmark International has acquired leading PACS connectivity platform PACSGEAR for a cash purchase price of approximately $54 million

It is hard to measure the indirect impact on medical imaging from the overall negative economic consequences of a government shutdown. However, the direct impact on practical day-to-day business operations should be fairly small judging by the contingency plans of various government agencies

Last year, the National Center for Policy Analysis (NCPA) referred to the 2.3% medical device excise tax as a “job killing” burden that would also “stifle innovation.” More than a year after the NCPA Issue Brief, the tax lives on